Search Results | Blood | American Society of Hematology

1-20 of 50

2 3

Sort by

Sort Order Select

Journal Articles

Increased Tumor-Associated CD66b+ Myeloid-Derived Suppressor Cells in Waldenstrom Macroglobulinemia Inhibit T-Cell Immune Function

Vaishali Bhardwaj, Shahrzad Jalali, Jose C. Villasboas, Zhi-Zhang Yang, Xinyi Tang, Prithviraj Mukherjee, Patrizia Mondello, Hyojin Kim, Rekha Mudappathi, Junwen Wang, Jordan E. Krull, Kerstin Wenzl, Anne J. Novak, Stephen M. Ansell

Blood (2022) 140 (Supplement 1): 2904–2905.

DOI: https://doi.org/10.1182/blood-2022-166450

Published: 2022

Journal Articles

IRF4 Shapes the Tumor Microenvironment of Follicular Lymphoma

Patrizia Mondello, Kerstin Wenzl, Zhi-Zhang Yang, Changjin Hong, Jordan E. Krull, Xinyi Tang, Vaishali Bhardwaj, Joseph P. Novak, Hyojin Kim, Prithviraj Mukherjee, Rebecca L. King, Tae Hyun Hwang, Mark J Shlomchik, Anne J. Novak, Stephen M. Ansell

Blood (2022) 140 (Supplement 1): 168–169.

DOI: https://doi.org/10.1182/blood-2022-157408

Published: 2022

Journal Articles

T-Cell Phenotype Varies in Distinct Tumor Microenvironments and CD57 + T FH Cells Are Associated with Disease Progression and Inferior Survival in Follicular Lymphoma

Zhi-Zhang Yang, Hyojin Kim, Hongyan Wu, Xinyi Tang, Jordan E. Krull, Jose Villasboas, Anne J. Novak, Stephen M. Ansell

Blood (2021) 138 (Supplement 1): 3522.

DOI: https://doi.org/10.1182/blood-2021-150804

Published: 2021

Journal Articles

Complete Remissions to PD-1 Blockade in Combination with Reduced-Dose ICE Chemotherapy in Two Cases of Relapsed or Refractory Classical Hodgkin Lymphoma with Bulky Lung Involvement after Failed PD-1 Blockade

Bing Xiu, Bing Li, Xinyu Zhu, Gangfeng Xiao, Xiu Luo, Zhi-Zhang Yang, Aibin Liang

Blood (2021) 138 (Supplement 1): 4368.

DOI: https://doi.org/10.1182/blood-2021-147134

Published: 2021

Journal Articles

Follicular Lymphoma Tumor-Cell Transcriptional Programs Associate with Distinct Somatic Alterations and Tumor-Immune Microenvironments

Jordan E. Krull, Kerstin Wenzl, Michelle K. Manske, Melissa A. Hopper, Melissa C. Larson, Vivekananda Sarangi, Matthew J. Maurer, Zhi-Zhang Yang, Lisa M. Rimsza, Brian K. Link, Thomas M. Habermann, Stephen M. Ansell, Rebecca L. King, James R. Cerhan, Anne J. Novak

Blood (2021) 138 (Supplement 1): 1327.

DOI: https://doi.org/10.1182/blood-2021-153873

Published: 2021

Journal Articles

High Dimensional Tissue-Based Spatial Analysis of the Tumor Microenvironment of Follicular Lymphoma Reveals Unique Immune Niches inside Malignant Follicles

Blood (2020) 136 (Supplement 1): 17–18.

DOI: https://doi.org/10.1182/blood-2020-134941

Published: 2020

Journal Articles

Pre-Existing T Cell Subsets Determine Anti-PD1 Blockade Response in Richter's Transformation

Prajish Iyer, PhD, Lu Yang, PhD, Zhi-Zhang Yang, PhD, Charla R. Secreto, Sutapa Sinha, PhD, Neil E. Kay, MD, Stephen M. Ansell, MD PhD, Lili Wang, MDPhD, Wei Ding, MD PhD, Hyojin Kim, PhD

Blood (2020) 136 (Supplement 1): 42–43.

DOI: https://doi.org/10.1182/blood-2020-138601

Published: 2020

Journal Articles

High-Dimensional and Single-Cell Transcriptome Analysis of AITL Tumor Microenvironment Reveals Gross Expansion of Novel Dysfunctional CD8+ T Cell Populations, Global Shift in B Cell Phenotypes

Joshua C. Pritchett, MD, Zhi-Zhang Yang, PhD, Hyojin Kim, PhD, Jose C Villasboas, MD, Andrew L. Feldman, MD, James R. Cerhan, MD PhD, Stephen M. Ansell, MD PhD

Blood (2020) 136 (Supplement 1): 42–43.

DOI: https://doi.org/10.1182/blood-2020-137219

Published: 2020

Journal Articles

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

Jordan Krull, BS, Kerstin Wenzl, PhD, Michelle Manske, MS, BS, Melissa Hopper, MSc, Melissa C. Larson, MS, Vivekananda Sarangi, Matthew J. Maurer, MS, Zhi-Zhang Yang, PhD, Lisa M. Rimsza, MD, Brian K. Link, MD, Thomas M. Habermann, MD, Stephen M. Ansell, MD PhD, Rebecca L. King, MD, James R. Cerhan, MD PhD, Anne J. Novak, PhD

Blood (2020) 136 (Supplement 1): 21–22.

DOI: https://doi.org/10.1182/blood-2020-142744

Published: 2020

Journal Articles

Malignant T-Cells and Normal Intratumoral T-Cells Have Similar Expression of Immune Checkpoint Molecules in Angioimmunoblastic T-Cell Lymphoma

Joshua C Pritchett, MD, Zhi-Zhang Yang, MD, Hyojin Kim, PhD, Jose C Villasboas, MD, Andrew L. Feldman, MD, James R. Cerhan, MD PhD, Stephen M Ansell, MD PhD

Blood (2019) 134 (Supplement_1): 1517.

DOI: https://doi.org/10.1182/blood-2019-131145

Published: 2019

Journal Articles

Immune Phenotyping of Cytotoxic T-Cells Reveals a Novel Population of TIM3 Expressing Cells That Lack PD1 and Are Associated with Good Outcomes in Marginal Zone Lymphoma

Theodora Anagnostou, MD, Zhi-Zhang Yang, MD, Hyojin Kim, PhD, Shahrzad Jalali, PhD, Jose C Villasboas, Hongyan Wu, PhD, Tammy Price-Troska, BS, Anne J Novak, PhD, Stephen M Ansell, MD PhD

Blood (2019) 134 (Supplement_1): 2790.

DOI: https://doi.org/10.1182/blood-2019-127757

Published: 2019

Journal Articles

Mass Cytometry Identifies a Novel Signature for Myeloid-Derived Suppressor-Cells in Waldenstrom's Macroglobulinemia

Shahrzad Jalali, PhD, Jose Villasboas, MD, Jie Shi, MD PhD, Cole Bothun, Hyojin Kim, PhD, Zhi-Zhang Yang, MD, Stephen M Ansell, MD

Blood (2019) 134 (Supplement_1): 3976.

DOI: https://doi.org/10.1182/blood-2019-124850

Published: 2019

Journal Articles

Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways

Blood (2019) 134 (Supplement_1): 1480.

DOI: https://doi.org/10.1182/blood-2019-126860

Published: 2019

Journal Articles

Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma

Patrizia Mondello, MD PhD MSc, Angelo Fama, MD, Melissa C Larson, Zhi-Zhang Yang, MD, Jose C Villasboas, Andrew L. Feldman, MD, Susan L Slager, PhD, Brian K. Link, MD, Sergei Syrbu, MD PhD, Anne J Novak, PhD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz Nowakowski, MD, James R. Cerhan, MD PhD, Stephen M Ansell, MD PhD

Blood (2019) 134 (Supplement_1): 121.

DOI: https://doi.org/10.1182/blood-2019-126233

Published: 2019

Journal Articles

Glutathione Metabolism Contributes to the Pathobiology of Waldenstrom's Macroglobulinemia

Shahrzad Jalali, PhD, Jie Shi, MD PhD, Hyojin Kim, PhD, Zhi-Zhang Yang, MD, Stephen M Ansell, MD

Blood (2019) 134 (Supplement_1): 3971.

DOI: https://doi.org/10.1182/blood-2019-124558

Published: 2019

Journal Articles

Prevalence and Regulation of Effector CD8 + T Cell Subsets in B-Cell NHL

Hongyan Wu, PhD, Zhi-Zhang Yang, MD, Hyo Jin Kim, PhD, Shahrzad Jalali, PhD, Tammy Price-Troska, BS, Stephen M. Ansell, MD PhD

Blood (2018) 132 (Supplement 1): 4134.

DOI: https://doi.org/10.1182/blood-2018-99-115374

Published: 2018

Journal Articles

Tigit Expression Defines a Subset of Activated T reg Cells with Prognostic Relevance in Follicular Lymphoma

Zhi-Zhang Yang, MD, Hyo Jin Kim, PhD, Shahrzad Jalali, PhD, Hongyan Wu, PhD, Tammy Price-Troska, BS, Stephen M. Ansell, MD PhD

Blood (2018) 132 (Supplement 1): 1590.

DOI: https://doi.org/10.1182/blood-2018-99-115328

Published: 2018

Journal Articles

Soluble PD-1 Ligands Regulate T-Cell Function in Waldenstrom's Macroglobulinemia

Shahrzad Jalali, PhD, Tammy Price-Troska, BS, Jose Villasboas Bisneto, MD, Hyo Jin Kim, PhD, Zhi Zhang Yang, Anne J Novak, PhD, Stephen M Ansell, MD PhD

Blood (2017) 130 (Supplement 1): 4034.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4034.4034

Published: 2017

Journal Articles

T-Cell Subsets and Macrophages in the Tumor Microenvironment Are Associated with Early Outcome in Follicular Lymphoma

Angelo Fama, MD, Andrew L Feldman, MD, Matthew J Maurer, MS, Brian K Link, MD, Anne J Novak, PhD, Zhi-Zhang Yang, MD, Hyo Jin Kim, PhD, Thomas M Habermann, MD, Thomas E Witzig, MD, James R. Cerhan, MD PhD, Stephen M Ansell, MD PhD

Blood (2017) 130 (Supplement 1): 4021.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4021.4021

Published: 2017

Journal Articles

Inhibiting IL-2 Signaling and the Regulatory T-Cell Pathway Using Computationally Designed Novel Peptides

Tammy Price-Troska, BS, David Diller, PhD, Alexander Bayden, PhD, Mark Jarosinski, PhD, Joseph Audies, PhD, Zhi-Zhang Yang, MD, Stephen M Ansell, MD, PhD

Blood (2016) 128 (22): 3875.

DOI: https://doi.org/10.1182/blood.V128.22.3875.3875

Published: 2016

2 3

NARROW

Increased Tumor-Associated CD66b+ Myeloid-Derived Suppressor Cells in Waldenstrom Macroglobulinemia Inhibit T-Cell Immune Function

IRF4 Shapes the Tumor Microenvironment of Follicular Lymphoma

T-Cell Phenotype Varies in Distinct Tumor Microenvironments and CD57 + T FH Cells Are Associated with Disease Progression and Inferior Survival in Follicular Lymphoma

Complete Remissions to PD-1 Blockade in Combination with Reduced-Dose ICE Chemotherapy in Two Cases of Relapsed or Refractory Classical Hodgkin Lymphoma with Bulky Lung Involvement after Failed PD-1 Blockade

Follicular Lymphoma Tumor-Cell Transcriptional Programs Associate with Distinct Somatic Alterations and Tumor-Immune Microenvironments

High Dimensional Tissue-Based Spatial Analysis of the Tumor Microenvironment of Follicular Lymphoma Reveals Unique Immune Niches inside Malignant Follicles

Pre-Existing T Cell Subsets Determine Anti-PD1 Blockade Response in Richter's Transformation

High-Dimensional and Single-Cell Transcriptome Analysis of AITL Tumor Microenvironment Reveals Gross Expansion of Novel Dysfunctional CD8+ T Cell Populations, Global Shift in B Cell Phenotypes

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

Malignant T-Cells and Normal Intratumoral T-Cells Have Similar Expression of Immune Checkpoint Molecules in Angioimmunoblastic T-Cell Lymphoma

Immune Phenotyping of Cytotoxic T-Cells Reveals a Novel Population of TIM3 Expressing Cells That Lack PD1 and Are Associated with Good Outcomes in Marginal Zone Lymphoma

Mass Cytometry Identifies a Novel Signature for Myeloid-Derived Suppressor-Cells in Waldenstrom's Macroglobulinemia

Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways

Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma

Glutathione Metabolism Contributes to the Pathobiology of Waldenstrom's Macroglobulinemia

Prevalence and Regulation of Effector CD8 + T Cell Subsets in B-Cell NHL

Tigit Expression Defines a Subset of Activated T reg Cells with Prognostic Relevance in Follicular Lymphoma

Soluble PD-1 Ligands Regulate T-Cell Function in Waldenstrom's Macroglobulinemia

T-Cell Subsets and Macrophages in the Tumor Microenvironment Are Associated with Early Outcome in Follicular Lymphoma

Inhibiting IL-2 Signaling and the Regulatory T-Cell Pathway Using Computationally Designed Novel Peptides

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only